Drug Shortage Report for SUBLINOX
Report ID | 146697 |
Drug Identification Number | 02391678 |
Brand name | SUBLINOX |
Common or Proper name | SUBLINOX |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | ZOLPIDEM TARTRATE |
Strength(s) | 5MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | SUBLINGUAL SUBLINGUAL |
Packaging size | 30 tabs |
ATC code | N05CF |
ATC description | HYPNOTICS AND SEDATIVES |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2021-09-08 |
Estimated end date | 2021-12-07 |
Actual end date | 2021-12-07 |
Shortage status | Resolved |
Updated date | 2021-12-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2021-12-09 | French | Compare |
v8 | 2021-12-09 | English | Compare |
v7 | 2021-11-30 | French | Compare |
v6 | 2021-11-30 | English | Compare |
v5 | 2021-11-10 | French | Compare |
v4 | 2021-11-10 | English | Compare |
v3 | 2021-10-05 | French | Compare |
v2 | 2021-10-05 | English | Compare |
v1 | 2021-10-05 | English | Compare |
Showing 1 to 9 of 9